Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Jul 23.
Published in final edited form as: Cell. 2019 Jan 10;176(1-2):404. doi: 10.1016/j.cell.2018.12.034

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer, Russell W Jenkins, David J Lieb, Jonathan H Chen, Dennie T Frederick, Michal Barzily-Rokni, Samuel S Freeman, Alexandre Reuben, Paul J Hoover, Alexandra-Chloé Villani, Elena Ivanova, Andrew Portell, Patrick H Lizotte, Amir R Aref, Jean-Pierre Eliane, Marc R Hammond, Hans Vitzthum, Shauna M Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M Reddy, Zachary A Cooper, Cloud P Paweletz, David A Barbie, Anat Stemmer-Rachamimov, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad Getz *, Nir Hacohen *
PMCID: PMC6647017  NIHMSID: NIHMS1006597  PMID: 30633907

In the originally published version of this article, the text associated with the vertical axis in Figure 6E mistakenly referred to the CD39TIM3/ CD39+TIM3+ ratio, but the values correspond to the inverse ratio, i.e., CD39+TIM3+/CD39TIM3. The corrected Figure 6E is shown here, and this error has now been corrected in the article online. The authors apologize for any confusion this error may have caused.

Figure 6E.

Figure 6E.

Differential Chromatin Accessibility in CD39+TIM3+ and CD39TIM3 cells (original)

Figure 6E.

Figure 6E.

Differential Chromatin Accessibility in CD39+TIM3+ and CD39TIM3 cells (corrected)

RESOURCES